Resibufogenin, a kind of bioactive compound of bufadienolide family extracted from toad venom (159), has been reported to upregulate RIPK3 to induce necroptosis in CRC cells in vivo, which significantly suppresses the growth and metastasis of CRC (149). The gene discussed is RIPK3; the disease is colorectal carcinoma.